Synapse

← Pharmaceutical Science Advances

Papers in Pharmaceutical Science Advances

Page 1 · newest first

  1. The substrate envelope strategy: Structural basis for resistance mitigation in antiviral drug designPharmaceutical Science Advances · 2026
  2. Gut Microbiota-Mediated Uric Acid Metabolism: Novel Insights for Developing Urate-Lowering and Anti-Gout MedicationsPharmaceutical Science Advances · 2026
  3. The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptidesPharmaceutical Science Advances · 2026
  4. Quorum Sensing Inhibitor-Antibiotic Conjugate Suppresses Virulence and Eradicates Intracellular Staphylococcus aureusPharmaceutical Science Advances · 2026
  5. Xiangsha Liujunzi Tang: A Promising Traditional Chinese Herbal Formula for Healing Gastric Mucosal Injury Through Pyroptosis Pathway ModulationPharmaceutical Science Advances · 2026
  6. Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPDPharmaceutical Science Advances · 2026
  7. From barrier to guide: Exploiting disease-specific hemodynamics for enhanced nanodrug targeting in cardiovascular diseasesPharmaceutical Science Advances · 2026
  8. A visualizable mitochondrial-targeted Chlorambucil prodrug for enhancing anti-hepatoma efficacyPharmaceutical Science Advances · 2026
  9. The gut-lung axis and viral pneumonia: Unrevealing the gut microbiotaPharmaceutical Science Advances · 2026
  10. Co-assembly of dipeptide and hydrophobic drug in hyaluronic acid through Schiff base reaction for the treatment of osteoarthritisPharmaceutical Science Advances · 2026
  11. In vivo immune cell engineering from bench to clinical realityPharmaceutical Science Advances · 2026
  12. Recent advances in the bioanalysis of acylcarnitines: Methodologies, challenges, and clinical perspectivesPharmaceutical Science Advances · 2026
  13. Calcium overload-induced apoptosis in cancer cells: ER-mitochondria crosstalk and therapeutic implicationsPharmaceutical Science Advances · 2026
  14. Recent Advances in HER2-Targeted Inhibitors for Cancer TherapyPharmaceutical Science Advances · 2026
  15. BGC1201: A potent allosteric SHP2 inhibitor with broad antitumor activity in lung, pancreatic, and esophageal cancer xenograftsPharmaceutical Science Advances · 2026
  16. Therapeutic potential of the sphingosine kinase 2 inhibitor opaganibPharmaceutical Science Advances · 2026
  17. Bio-based nanomaterials in drug delivery: An updated reviewPharmaceutical Science Advances · 2026
  18. Discovery of Novel Kir4.1 Inhibitors Based on Serdemetan with Potential Therapy for Glioblastoma-Depression ComorbidityPharmaceutical Science Advances · 2026
  19. Repurposing Radiopharmaceutical Carriers for Targeted Drug Delivery and Theranostics: A Translational FrameworkPharmaceutical Science Advances · 2026
  20. Uncovering a photoprotective polysaccharide from Gentiana dahurica via systematic fractionationPharmaceutical Science Advances · 2026
  21. The design and performing of animal experiments were approved by the Institutional Animal Care and Use Committees at Shandong University. APPROVAL NUMBER: KYLL-2023(ZM)-576.Fufang Huangbo Formula mitigates myeloproliferative neoplasms by activating p53/p21 signaling axis and inhibiting STAT3 and NF-κB signaling pathwaysPharmaceutical Science Advances · 2026
  22. Artificial Intelligence-Driven Discovery of Coumarin-Based Therapeutics: Revolutionizing Target Identification and ValidationPharmaceutical Science Advances · 2026
  23. Functional identification of key enzymes in calycosin biosynthesis in Astragalus membranaceus and establishment of heterologous expression systemPharmaceutical Science Advances · 2026
  24. Toxicity of nanostructures in drug delivery applicationsPharmaceutical Science Advances · 2026
  25. Unleashing the Power of DNA-Encoded Libraries for Challenging Targets in Drug DiscoveryPharmaceutical Science Advances · 2026
  26. Next-generation Janus kinase inhibitors: Integrating synthetic innovation, structural biology, and computational design for precision drug discoveryPharmaceutical Science Advances · 2026
  27. Qualitative and quantitative standardisation of Epilobium angustifolium L. leaves according to Pharmacopoeial requirementsPharmaceutical Science Advances · 2026
  28. Recent advances in chemiluminescence probes for Tumor microenvironment with applications in cancer diagnosis and therapyPharmaceutical Science Advances · 2026
  29. Breaking through the radiation dilemma: development and clinical translation of anti-radiation drugsPharmaceutical Science Advances · 2026
  30. NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCLPharmaceutical Science Advances · 2026
  31. Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapyPharmaceutical Science Advances · 2026
  32. The bidirectional interface between oral drug and the gut microbiome: Implications for drug deliveryPharmaceutical Science Advances · 2026
  33. Computational screening of Sophora flavescens phytochemicals as potential aromatase inhibitors: Molecular docking, ADMET, Network pharmacology, Molecular dynamics simulation, and DFT studiesPharmaceutical Science Advances · 2026
  34. Metabolomic profiling of Musanga cecropioides leaf extract reveals cytotoxic mechanisms in MCF-7 breast cancer cellsPharmaceutical Science Advances · 2025
  35. Graminoides A-D, antibacterial cyclic octaketides from the desert-derived StreptomycesPharmaceutical Science Advances · 2025
  36. Convergence of computer-aided drug discovery and artificial intelligence: Towards next-generation therapeuticsPharmaceutical Science Advances · 2025
  37. Curcumin-loaded gelatin ethosomal gel: A novel approach for anti-inflammatory efficacyPharmaceutical Science Advances · 2025
  38. Discovery of a long-acting nanocrystal formulation of INND-2201, a new co-drug of pregabalin and palmitoylethanolamide with synergistic analgesic effectsPharmaceutical Science Advances · 2025
  39. Metal-organic frameworks in pharmaceutical researchPharmaceutical Science Advances · 2025
  40. Conquering viral drug resistance: Structural and mechanistic paradigms for antiresistance drug designPharmaceutical Science Advances · 2025
  41. Curative antimalarial efficacy and hepato-renal protective effects of Melochia umbellata leaf extract in rats infected with Plasmodium bergheiPharmaceutical Science Advances · 2025
  42. A biodegradable antimicrobial oligomer-containing hydrogel for drug-resistant bacteria-infected skin wound treatmentPharmaceutical Science Advances · 2025
  43. The applications of single-cell multiomics in drug screeningPharmaceutical Science Advances · 2025
  44. Targeted RNA base editing for therapeutic: mechanisms and advancesPharmaceutical Science Advances · 2025
  45. Enhancing ferroptosis and inhibiting ABCB1 make the novel aldose reductase inhibitor 5F-E a promising sensitizer in liver cancerPharmaceutical Science Advances · 2025
  46. An investigation into the underlying mechanisms of risperidone-induced antinociception through the cholinergic pathwayPharmaceutical Science Advances · 2025
  47. Nanoplatforms in sepsis storm: Multimodal synergy for precision immunomodulation and pathogen neutralizationsPharmaceutical Science Advances · 2025
  48. Circular RNA: From non-coding regulators to functional protein encodersPharmaceutical Science Advances · 2025
  49. Phenol and chromone compounds for in silico inhibition of nsP2 and nsP3 of Chikungunya virusPharmaceutical Science Advances · 2025
  50. Protective activity of Basella alba l. Leaf extract on cardiac injury markers following intestinal ischemia-reperfusion: potential for cardiovascular therapyPharmaceutical Science Advances · 2025